Pinning Down Presbyopia Management: New and Emerging Pharmacologic Treatments (CE Monograph)
hosted byMedEdicus LLCPinning Down Presbyopia Management: New and Emerging Pharmacologic Treatments (CE Monograph) is organized by MedEdicus LLC.
Course opens: 06/15/2023
Course expires: 06/30/2024
Description:
Presbyopia is a common cause of visual impairment affecting most adults aged ? 40 years. Limitations of conventional methods for presbyopia correction have spurred the development of topical pharmacologic agents as an alternative intervention, with major focus on medications that employ the principles of small aperture optics by inducing miosis. One pharmacologic treatment for presbyopia is already commercially available, another product is undergoing regulatory review for licensing, and others are advancing through clinical trials. This is Part 2 of a 2-part educational activity series designed to enable optometrists to successfully implement pharmacologic treatments for presbyopia for appropriately selected patients. Part 2 reviews the mechanisms of action of the active ingredients found in the approved and investigational topical drops and presents available data from premarketing clinical trials investigating the efficacy and safety of these medications. Through case-based discussions and by sharing their personal experiences, expert faculty provide insights on identifying appropriate candidates for miotic drops, patient counseling, and the practice-building potential of miotics.
Learning Objectives
After completing this activity, participants will be better able to:
• Discuss the mechanisms of action of the active ingredients in new and emerging pharmacologic treatments for presbyopia
• Review clinical efficacy and safety of miotics to treat presbyopia
• Identify characteristics to guide selection of patients who would or would not benefit from miotic treatment for presbyopia
Additional details will be posted as soon as information is available.
